Vivos (RDGL) Gross Profit Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | Vivos | - | - | -3,105.00 | 41.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.25% |
| Sep 30, 2025 | -1,285.48% |
| Jun 30, 2025 | -1,377.68% |
| Mar 31, 2025 | -505.53% |
| Dec 31, 2024 | 41.28% |
| Sep 30, 2024 | -84.56% |
| Jun 30, 2024 | 208.80% |
| Mar 31, 2024 | 2.34% |
| Dec 31, 2023 | -112.92% |
| Sep 30, 2023 | 207.12% |
| Jun 30, 2023 | -129.47% |
| Mar 31, 2023 | -115.36% |
| Dec 31, 2022 | 29.55% |
| Sep 30, 2022 | -173.53% |
| Mar 31, 2018 | 134.56% |
| Dec 31, 2017 | -108.33% |
| Sep 30, 2017 | 15.05% |
| Jun 30, 2017 | 88.42% |
| Mar 31, 2017 | -181.98% |
| Dec 31, 2016 | 21,353,800.00% |
| Sep 30, 2016 | -613.91% |
| Jun 30, 2016 | -154,787.06% |
| Mar 31, 2016 | -166.72% |
| Dec 31, 2015 | 100.01% |
| Sep 30, 2015 | 4,648.30% |
| Jun 30, 2015 | -100.87% |
| Mar 31, 2015 | -13.30% |
| Dec 31, 2014 | -2,627.27% |
| Sep 30, 2014 | -101.71% |
| Jun 30, 2014 | 258.28% |
| Mar 31, 2014 | -33.54% |
| Dec 31, 2013 | -104.37% |
| Sep 30, 2013 | -72.50% |
| Jun 30, 2013 | -112.96% |
| Mar 31, 2013 | -66.15% |
| Dec 31, 2012 | -69.50% |
| Sep 30, 2012 | 46.85% |
| Jun 30, 2012 | -62.99% |
| Mar 31, 2012 | 57.31% |
| Dec 31, 2011 | -89.30% |
| Sep 30, 2011 | -52.92% |
| Jun 30, 2011 | 3.84% |